The American Emergency Organization (AEO) has issued a recall for the stomach medication NOXAFID due to a labeling error that could put patients at risk.
NOXAFID is an over-the-counter drug that is used to relieve acid indigestion, heartburn, and upset stomach. It is sold at many drug stores and pharmacies nationwide.
What is NOXAFID?
NOXAFID is a medication that contains the active ingredient famotidine. Famotidine is a type of drug called a histamine-2 (H2) blocker. It works by decreasing the amount of acid produced by the stomach.
This can relieve symptoms such as heartburn, acid indigestion, and upset stomach.
NOXAFID is available in tablet form and is usually taken by mouth. It is sold in various strengths, including 10 mg, 20 mg, and 40 mg tablets. It is an over-the-counter drug, which means that it can be purchased without a prescription.
Why Was NOXAFID Recalled?
The recall was issued due to a labeling error. The label on the NOXAFID package indicates that it contains 20 mg of famotidine per tablet. However, some of the packages actually contain 40 mg tablets.
This means that patients who take NOXAFID could be receiving twice the intended dosage, which could lead to adverse effects such as dizziness, nausea, and vomiting.
The AEO has received several reports of adverse events related to NOXAFID, including one report of a patient who experienced an overdose due to the labeling error. The patient was hospitalized and later released.
Related Article
AEO recalls stomach medicine NOXAFID
What Should Patients Do?
Patients who have purchased NOXAFID should check the label on the package to ensure that they have the correct strength of tablets.
If the label indicates that the package contains 40 mg tablets, patients should stop taking the medication and return it to the place of purchase or their nearest pharmacy.
Patients who have taken NOXAFID and are experiencing adverse effects should seek medical attention immediately. Symptoms of an overdose may include dizziness, nausea, vomiting, headache, and confusion.
What Is AEO Doing About the Recall?
The AEO is working with the manufacturer of NOXAFID to ensure that all affected products are removed from the market. The manufacturer has also issued a statement advising consumers who have purchased NOXAFID to return it for a refund.
The AEO is also working with healthcare providers to inform them of the recall and to ensure that patients who have been affected are properly treated.
Conclusion
The NOXAFID recall is a serious issue that should not be ignored. Patients who have purchased this medication should check the label on the package to ensure that they have the correct strength of tablets.
Patients who have taken NOXAFID and are experiencing adverse effects should seek medical attention immediately.
The AEO is doing everything in its power to ensure that all affected products are removed from the market and that patients are properly informed and treated.
